1. 河南省科技厅，BP1 在非小细胞肺癌顺铂耐药中的作用及机制研究，项目号：242102310311，2024.01-2025.12，主持，在研。
2. 河南省教育厅，基于微管靶点的四氢喹喔啉类化合物A3抗肿瘤多药耐药作用及其机制研究，项目号：20A310003，3万，2020.01-2021.12，主持，结项。
3. 国家自然科学基金委，多胺通过调节p-糖蛋白诱导肿瘤细胞多药耐药的机制研究，项目号：U1404819，30万，2015.01-2017.12，主持，结项。
4. 河南省科技厅，蒽醌衍生物抗肝癌作用机制研究，项目号：132300410228，2013.01-2015.12，主持，结项。
5. 河南省教育厅，靶向性多胺-萘酰亚胺缀合物对肝癌细胞PKC通路的调控，项目号：2011B310003，2011.01-2013.12，主持，结项。
6.博士后基金，靶向性多胺－萘酰亚胺缀合物对肝癌细胞信号PKC通路调控的机制研究，项目号：20100470995，3万，2010.01-2013.12，主持，结项。
1. Liang Tingting; Dong Haiyang; Wang Zhuangzhuang; Lu Lu; Song Xueting; Qi Jianguo; Zhang Yahong*; Wang Jianhong*; Du Guanhua*. Discovery of novel urea derivatives as ferroptosis and autophagy inducer for human colon cancer treatment. European Journal of Medicinal Chemistry, 2024, 268:116277.
2. Liang Tingting; Zhou Xiaomin; Lu Lu; Dong Haiyang; Zhang Yanan; Xu Yungen; Qi Jianguo; Zhang Yahong*; Wang Jianhong*. Structure-activity relationships and antiproliferative effects of 1,2,3,4-4H-quinoxaline derivatives as tubulin polymerization inhibitors, Bioorganic Chemistry, 2021, 110: 104793.
3. Xing Cuili; Fang Yan; Jiang Lei; Zhang Yahong*; Li Mingxue*. Diorganotin(IV) complexes derived from N-terminal methylation of Triapine: synthesis, characterization and antibacterial activity evaluation, Journal of Organometallic Chemistry, 2020, 911: 12115.
4. Qi Jianguo; Huang Jing; Zhou Xiaomin; Luo Wen; Xie Jiaxin; Niu Linqiang; Yan Zhijie; Lu Yang; Men Yuhui; Chen Yanan; Zhang Yahong*; Wang Jianhong*. Synthesis and biological evaluation of quinoxaline derivatives as tubulin polymerization inhibitors that elevate intracellular ROS and triggers apoptosis via mitochondrial pathway, Chemical Biology & Drug Design, 2019, 93(4): 617-627.
5. Qi Jianguo; Dong Haiyang; Huang Jing; Zhang Shufeng; Niu Linqiang; Zhang Yahong*; Wang Jianhong*. Synthesis and biological evaluation of N-substituted 3-oxo-1,2,3,4-tetrahydro-quinoxaline-6-carboxylic acid derivatives as tubulin polymerization inhibitors, European Journal of Medicinal Chemistry, 2018, 143: 8-20.
